Literature DB >> 2838437

Increased amounts of D-enantiomer dependent on alkaline concentration in the synthesis of L-[methyl-11C]methionine.

K Ishiwata1, T Ido, W Vaalburg.   

Abstract

The presence of D-enantiomer in L-[methyl-11C]methionine prepared from [11C]CH3I and L-homocysteine thiolactone, was measured by high performance liquid chromatography using a reverse-phase column with an eluent containing L-proline and cupric acetate. The amount of D-enantiomer increased with concentration of NaOH used. The reaction time, 2-10 min, and the reaction temperature, 40 degrees-80 degrees C, have only minor effect on the formation of D-enantiomer. No significant difference was found for three different lots of L-homocysteine thiolactone. At the highest concentration investigated, 1.0 M NaOH in 50% aqueous acetone, the percentage of D-enantiomer was found to be 7.7%. With 0.025 M NaOH used only 2.1% was measured. When L-[methyl-11C]methionine was incubated in 1.0 M NaOH, no conversion of L- into D-enantiomer was observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838437     DOI: 10.1016/0883-2889(88)90021-4

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  11 in total

1.  Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

Authors:  Nobuyuki Kawai; Yukito Maeda; Nobuyuki Kudomi; Keisuke Miyake; Masaki Okada; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

2.  Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.

Authors:  Yoshiro Kawase; Yuka Yamamoto; Reiko Kameyama; Nobuyuki Kawai; Nobuyuki Kudomi; Yoshihiro Nishiyama
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

3.  Metabolic fate of L-[methyl-11C]methionine in human plasma.

Authors:  K Ishiwata; J Hatazawa; K Kubota; M Kameyama; M Itoh; T Matsuzawa; T Takahashi; R Iwata; T Ido
Journal:  Eur J Nucl Med       Date:  1989

4.  Use of 11C-methionine positron emission tomography in basal germinoma: assessment of treatment response and residual tumor.

Authors:  Nobuyuki Kawai; Keisuke Miyake; Yuka Yamamoto; Yoshihiro Nishiyama; Yukito Maeda; Teruki Kageji; Takashi Tamiya
Journal:  Childs Nerv Syst       Date:  2009-03-19       Impact factor: 1.475

5.  Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.

Authors:  Shuichi Okubo; Hai-Ning Zhen; Nobuyuki Kawai; Yoshihiro Nishiyama; Reiji Haba; Takashi Tamiya
Journal:  J Neurooncol       Date:  2010-01-21       Impact factor: 4.130

6.  Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy.

Authors:  Benjamin S Laser; Thomas E Merchant; Daniel J Indelicato; Chia-Ho Hua; Barry L Shulkin; Scott E Snyder
Journal:  Neuro Oncol       Date:  2013-02-13       Impact factor: 12.300

7.  11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.

Authors:  Y Yamamoto; Y Nishiyama; N Kimura; R Kameyama; N Kawai; T Hatakeyama; M Kaji; M Ohkawa
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

8.  11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.

Authors:  Tetsuhiro Hatakeyama; Nobuyuki Kawai; Yoshihiro Nishiyama; Yuka Yamamoto; Yasuhiro Sasakawa; Tomotsugu Ichikawa; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

9.  11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Authors:  Sungeun Kim; June-Key Chung; So-Hyang Im; Jae Min Jeong; Dong Soo Lee; Dong Gyu Kim; Hee Won Jung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-10       Impact factor: 9.236

10.  [11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.

Authors:  Christian Pötzi; Alexander Becherer; Christine Marosi; Georgios Karanikas; Monika Szabo; Robert Dudczak; Kurt Kletter; Susanne Asenbaum
Journal:  J Neurooncol       Date:  2007-05-11       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.